Myeloid Therapeutics
Clinical trials sponsored by Myeloid Therapeutics, explained in plain language.
-
First patients dosed in new cancer drug trial
Disease control Recruiting nowThis is the first study in people to test a new drug called MT-304 for adults with advanced cancers that have a protein called HER2. The main goals are to check the safety of the drug, find the best dose, and see if it shows any early signs of helping to control the cancer. Parti…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
First patients to receive experimental liver cancer drug
Disease control Recruiting nowThis is the first study in humans testing a new drug called MT-303 for advanced liver cancer that has spread or cannot be removed by surgery. Researchers will give the drug alone or combined with standard cancer medications to 70 participants to find the safest dose and see if it…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC